Mohamad Maghnie
Overview
Explore the profile of Mohamad Maghnie including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
193
Citations
2449
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Guillen-Navarro E, AlSayed M, Alves I, Ben-Omran T, Boero S, Cormier-Daire V, et al.
Orphanet J Rare Dis
. 2025 Mar;
20(1):114.
PMID: 40065464
Background: Achondroplasia is one of the most prevalent forms of skeletal dysplasia. Lifelong follow-up by an experienced multidisciplinary team is required, particularly during the first 2 years. In 2021, international...
2.
Capalbo D, Moracas C, Guazzarotti L, Baronio F, Stancampiano M, Ortolano R, et al.
J Clin Endocrinol Metab
. 2025 Feb;
PMID: 39919031
Context: There has been concern about a potential increase in the incidence or severity of Coronavirus Disease 2019 (COVID-19) in individuals with adrenal insufficiency (AI). Data on the course of...
3.
Savarirayan R, Hoover-Fong J, Ozono K, Backeljauw P, Cormier-Daire V, DeAndrade K, et al.
Nat Rev Endocrinol
. 2025 Jan;
PMID: 39757323
Achondroplasia is the most common genetic form of short-limbed skeletal dysplasia (dwarfism). Clinical manifestations and complications can affect individuals across the lifespan, including the need for adaptations for activities of...
4.
Maniatis A, Cutfield W, Dattani M, Deal C, Collett-Solberg P, Horikawa R, et al.
J Clin Endocrinol Metab
. 2024 Dec;
PMID: 39672599
Context: Several long-acting growth hormone (LAGH) therapies have recently become available, but guidance on their usage in children with growth hormone (GH) deficiency is limited. Methods: International experts in pediatric...
5.
Tantari G, Bassi M, Pistorio A, Minuto N, Napoli F, Piccolo G, et al.
Front Endocrinol (Lausanne)
. 2024 Dec;
15:1439901.
PMID: 39649219
Background: Insulin resistance in children and adolescents with obesity is linked to increased risk of type 2 diabetes mellitus and cardiovascular disease. The SPISE index, based on values of fasting...
6.
Panicucci C, Casalini S, Angelelli A, Brolatti N, Pedemonte M, Patti G, et al.
Muscle Nerve
. 2024 Dec;
71(2):191-199.
PMID: 39648958
Introduction/aims: Duchenne muscular dystrophy (DMD) is complicated by bone fragility. This study aimed to elucidate changes in bone mineral density (BMD) and body composition over time and to explore associations...
7.
Chioma L, Patti G, Cappa M, Maghnie M
J Endocrinol Invest
. 2024 Nov;
PMID: 39520641
No abstract available.
8.
Bassi M, Strati M, Spiandorello G, Scalas M, Cresta F, Calevo M, et al.
Life (Basel)
. 2024 Oct;
14(10).
PMID: 39459609
Introduction: The impact of ETI therapy on pulmonary function and nutritional status has been widely studied; the literature on the possible outcomes on glycemic control and insulin requirement in patients...
9.
Pezzotta F, Sarale N, Spacco G, Tantari G, Bertelli E, Bracciolini G, et al.
Children (Basel)
. 2024 Oct;
11(10).
PMID: 39457190
The case report shows the safety and efficacy of insulin treatment with Advanced Hybrid Closed Loop (AHCL) system in a young patient affected by permanent neonatal diabetes mellitus (PNDM) due...
10.
Vimercati A, Tannorella P, Guzzetti S, Calzari L, Gentilini D, Manfredini E, et al.
J Clin Endocrinol Metab
. 2024 Oct;
PMID: 39412159
Context: Silver-Russell Syndrome (SRS) is a growth retardation disorder characterized by pre- and post-natal growth failure, relative macrocephaly at birth, prominent forehead, body asymmetry, and feeding difficulties. The main molecular...